Enhanced therapeutic effects for human pancreatic cancer by application K-ras and IGF-IR antisense oligodeoxynucleotides

Figure 2 Sequence analysis of pancreatic cancer cell line Patu8988 (A) and BXCP-3 (B). Patu8988 had K-ras point mutation at codon 12 and its style was GGT→GTT (indicated in the square). BXCP-3 was a K-ras gene wild type cell line with normal GGT at codon 12; No other mutation styles were found.